Jean‐François Viallard

Eosinophilic granulomatosis with polyangiitis (Churg‐Strauss): Clinical characteristics and long‐term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort

Cloé Comarmond, Christian Pagnoux, Mehdi Khellaf et al. · Arthritis & Rheumatism · 2012 · 889 citations

Antineutrophil Cytoplasmic Antibodies and the Churg–Strauss Syndrome

R. Sablé-Fourtassou, Pascal Cohen, Alfred Mahr et al. · Annals of Internal Medicine · 2005 · 682 citations

Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2)

Pierre Charles, Benjamin Terrier, Élodie Perrodeau et al. · Annals of the Rheumatic Diseases · 2018 · 325 citations

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

Jérôme Avouac, Élodie Drumez, É. Hachulla et al. · The Lancet Rheumatology · 2021 · 290 citations · Full text

Rheumatoid Disorder, Rheumatology, Autoimmune Disease +9

Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus

Patrick Blanco, Vincent Pitard, Jean‐François Viallard et al. · Arthritis & Rheumatism · 2005 · 257 citations